JANET JAMES: Open Payments
NPI 1386060358 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$697 in 32 payments from 15 companies in 2025. Trend: 2023 $879 · 2024 $963 · 2025 $697
Food & beverage: $697
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 8 | $176 |
| Lilly USA, LLC | 4 | $84 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $77 |
| Neurocrine BioSciences, Inc. | 3 | $61 |
| Ascensia Diabetes Care US Inc. | 2 | $47 |
| Novo Nordisk Inc | 2 | $47 |
| Amgen Inc. | 2 | $39 |
| Radius Health, Inc. | 1 | $29 |
| Ascendis Pharma Endocrinology Inc | 1 | $27 |
| Insulet Corporation | 1 | $24 |
Products named: FREESTYLE LIBRE 3, JARDIANCE, MOUNJARO, CRENESSITY, Ozempic, Tymlos, Yorvipath, Omnipod.
Industry payments across MO — which companies pay providers there.
